Analysis of FGFR alterations from circulating tumor DNA (ctDNA) and Tissue in a phase II trial of erdafitinib in urothelial carcinoma (UC).

被引：3
|
作者：
Santiago-Walker, Ademi E.
Moy, Christopher
Cherkas, Yauheniya
Loriot, Yohann
Siefker-Radtke, Arlene O.
Motley, Clifford
Avadhani, Anjali Narayan
OHagan, Anne
De Porre, Peter
Lorenzi, Matthew V.
McCaffery, Ian
机构：
[1] Janssen Res & Dev LLC, Spring House, PA USA
[2] Inst Cancerol Gustave Roussy, Villejuif, France
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Janssen Res & Dev, Beerse, Belgium
[5] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
420
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Concordance Analysis of Tissue and Circulating Tumor DNA (ctDNA) in Renal Cell Carcinoma (RCC): Insights from a Multimodal Real-World Database
    Jani, Chinmay
    Tran, Elizabeth
    Hockenberry, Adam
    Jaeger, Ellen
    Husni, Nabil
    Stoppler, Melissa
    Mercer, Jacob
    Pal, Sumanta
    Agarwal, Neeraj
    Choueiri, Toni
    Rose, Brent
    Bagrodia, Aditya
    Mckay, Rana
    ONCOLOGIST, 2024, 29 : S6 - S7
  • [22] Matched tissue and circulating tumor DNA (ctDNA) analysis in renal cell carcinoma (RCC): Results from a multimodal real-world database
    McKay, Rana R.
    Jani, Chinmay
    Tran, Eli
    Hockenberry, Adam J.
    Jaeger, Ellen B.
    Husni, Nabil
    Stoppler, Melissa Conrad
    Mercer, Jacob
    Pal, Sumanta Kumar
    Agarwal, Neeraj
    Choueiri, Toni K.
    Rose, Brent S.
    Bagrodia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] The genomic landscape of metastatic urothelial carcinoma from circulating tumor DNA.
    Vandekerkhove, Gillian R.
    Annala, Matti
    Lavoie, Jean-Michel
    Sundahl, Nora
    Walz, Simon
    Sano, Takeshi
    Murtha, Andrew
    Todenhoefer, Tilman
    Ost, Piet
    Chi, Kim N.
    Black, Peter C.
    Eigl, Bernhard
    Wyatt, Alexander W.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 29 - 29
  • [24] Association of circulating tumor (ct)-DNA genomic alterations (GA) with outcomes in metastatic urothelial carcinoma (mUC)
    Grivas, Petros
    Pond, Gregory Russell
    Nagy, Rebecca J.
    Barata, Pedro C.
    Mendiratta, Prateek
    Gopalakrishnan, Dharmesh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Circulating tumor (ct)-DNA alterations in advanced urothelial carcinoma: Association with outcomes and evolution with therapy.
    Grivas, Petros
    Nagy, Rebecca J.
    Pond, Gregory Russell
    Gupta, Sumati
    Wang, Jue
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [26] Comparison of circulating tumor DNA (ctDNA) profile in metastatic urothelial carcinoma (mUC) derived from the upper tract (UT) and lower tract (LT)
    Agarwal, N.
    Pal, S. K.
    Sonpavde, G.
    Kiedrowski, L. A.
    Nagy, R. J.
    Banks, K.
    Lanman, R.
    Grivas, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Longitudinal circulating tumor DNA profiling of metastatic urothelial carcinoma in the POLARIS-03 trial
    Chen, H.
    Zhang, R.
    Xie, F.
    Zhang, Y.
    Wang, Y.
    Shahatiaili, A.
    Zang, J.
    Du, P.
    Jia, S.
    Xue, W.
    Zhuang, G.
    Huang, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S395 - S395
  • [28] A phase II randomized therapeutic optimization trial for subjects with refractory metastatic colorectal cancer using circulating tumor DNA (ctDNA): Rapid 1 trial
    Rogers, Sherise C.
    Wang, Shu
    Thomas, Ryan Michael
    Ramnaraign, Brian Hemendra
    Fabregas, Jesus C.
    Sahin, Ilyas
    Staal, Stephen
    Murphy, Martina Cathryn
    Murillo, Anna Melissa Singson
    Markham, Merry Jennifer
    Kaye, Frederic J.
    Heldermon, Coy D.
    Jones, Dennie V.
    Dang, Nam H.
    Close, Julia Lee
    George, Thomas J.
    Allegra, Carmen Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [29] Prognostic Implications of Cerebrospinal Fluid Circulating Tumor DNA (CSF ctDNA) Following Radiation Therapy in Patients with Leptomeningeal Metastasis: Analysis of a Randomized Phase II Trial
    Goglia, A. G.
    Yang, J. T.
    Kratochvil, L. B.
    Yerramilli, D.
    Higginson, D. S.
    Miller, A.
    Berger, M.
    Powell, S. N.
    Boire, A.
    Wijetungah, N. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S69 - S70
  • [30] Plasma Circulating Tumor DNA (ctDNA) as an Alternative to Tissue DNA for Genotyping of DLBCL: Results from the POLARIX Study
    Jardin, Fabrice
    Raghavan, Vibha
    Tracy, Samuel
    Balasubramanian, Sandhya
    Sehn, Laurie H.
    Flowers, Christopher R.
    Morschhauser, Franck
    Herrera, Alex F.
    Trneny, Marek
    Sharman, Jeff P.
    Salles, Gilles
    Tilly, Herve
    Friedberg, Jonathan W.
    Harris, Will
    Hirata, Jamie H.
    Lee, Calvin
    Jiang, Yanwen
    Lenz, Georg
    BLOOD, 2023, 142
12345